0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Next-Generation Sequencing (NGS) Services Market Research Report 2026
Published Date: 2026-02-13
|
Report Code: QYRE-Auto-38C8922
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Next Generation Sequencing NGS Services Market Insights and Forecast to 2028
BUY CHAPTERS

Global Next-Generation Sequencing (NGS) Services Market Research Report 2026

Code: QYRE-Auto-38C8922
Report
2026-02-13
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Next-Generation Sequencing (NGS) Services Market Size

The global Next-Generation Sequencing (NGS) Services market was valued at US$ 26150 million in 2025 and is anticipated to reach US$ 74650 million by 2032, at a CAGR of 16.4% from 2026 to 2032.

Next-Generation Sequencing (NGS) Services Market

Next-Generation Sequencing (NGS) Services Market

Next-Generation Sequencing (NGS) Services refer to comprehensive genetic analysis solutions based on high-throughput sequencing platforms, enabling the detection and analysis of genomic, transcriptomic, and epigenomic information at multiple levels. By leveraging parallelized, large-scale, and high-precision sequencing, NGS dramatically improves the efficiency and accuracy of genetic data acquisition, generating massive DNA or RNA sequence datasets in a single run. These services encompass the entire workflow, including sample preparation, library construction, sequencing operations, data processing, and bioinformatics analysis, while offering customized solutions for diverse needs such as research, clinical diagnostics, drug development, agricultural breeding, and microbiology studies. With advantages in cost efficiency, data depth, and application breadth, NGS services have become an essential infrastructure and innovation driver in precision medicine, life sciences, and the biotechnology industry.
The accelerated implementation of global precision medicine strategies and continuous advancements in bioinformatics are creating vast growth opportunities for the NGS services market. Increased government funding for genomics research and clinical translation projects such as early cancer screening is driving demand expansion among hospitals, research institutions, and biopharmaceutical companies. With significant reductions in sequencing costs and faster turnaround times, NGS has transitioned from exploratory research to large-scale clinical applications, covering areas such as tumor profiling, companion diagnostics, pathogen detection, and rare disease screening. Across the value chain, deeper collaborations between platform technology providers, service operators, and downstream application sectors are accelerating the adoption of new service models and value-added applications.
Despite rapid growth, the NGS services market faces challenges such as the lack of standardized data interpretation protocols, stringent regulatory requirements for clinical applications, and compliance risks related to data security. Regulatory differences across countries and regions increase the complexity of cross-border operations. High-quality bioinformatics analysis depends on experienced technical teams and robust computing infrastructure, creating barriers to entry. Certain niche segments demand extremely high sequencing accuracy and sensitivity, requiring continuous investment in R&D and quality control. Additionally, as market competition intensifies, balancing price pressures with differentiated service capabilities has become a critical test for business sustainability and expansion.
In the coming years, downstream demand for NGS services will diversify and integrate across multiple sectors. In healthcare, personalized treatment and early disease screening will continue to expand, particularly in the precision diagnosis of cancer, infectious diseases, and genetic disorders. In the biopharmaceutical industry, NGS will play a key role in new drug target discovery, elucidating drug response mechanisms, and stratifying patients in clinical trials. Agriculture and environmental sciences will further leverage NGS for crop improvement, animal breeding, and microbiome monitoring. Meanwhile, AI-driven automated analysis and cloud-based data collaboration will drive NGS services toward higher efficiency and broader accessibility, meeting the growing need for real-time, large-scale, multidimensional genetic information in both research and industrial applications.
This report delivers a comprehensive overview of the global Next-Generation Sequencing (NGS) Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Next-Generation Sequencing (NGS) Services. The Next-Generation Sequencing (NGS) Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Next-Generation Sequencing (NGS) Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Next-Generation Sequencing (NGS) Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Next-Generation Sequencing (NGS) Services Market Report

Report Metric Details
Report Name Next-Generation Sequencing (NGS) Services Market
Accounted market size in 2025 US$ 26150 million
Forecasted market size in 2032 US$ 74650 million
CAGR 16.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Targeted Sequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
Segment by Application
  • Hospitals and Clinics
  • Biopharma Companies
  • Academic & Research Organizations
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Thermo Fisher Scientific, Macrogen, Oxford Nanopore, Novogene, Pacific Biosciences, Azenta Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Next-Generation Sequencing (NGS) Services companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Next-Generation Sequencing (NGS) Services Market growing?

Ans: The Next-Generation Sequencing (NGS) Services Market witnessing a CAGR of 16.4% during the forecast period 2026-2032.

What is the Next-Generation Sequencing (NGS) Services Market size in 2032?

Ans: The Next-Generation Sequencing (NGS) Services Market size in 2032 will be US$ 74650 million.

Who are the main players in the Next-Generation Sequencing (NGS) Services Market report?

Ans: The main players in the Next-Generation Sequencing (NGS) Services Market are Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Thermo Fisher Scientific, Macrogen, Oxford Nanopore, Novogene, Pacific Biosciences, Azenta Life Sciences

What are the Application segmentation covered in the Next-Generation Sequencing (NGS) Services Market report?

Ans: The Applications covered in the Next-Generation Sequencing (NGS) Services Market report are Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations, Others

What are the Type segmentation covered in the Next-Generation Sequencing (NGS) Services Market report?

Ans: The Types covered in the Next-Generation Sequencing (NGS) Services Market report are Targeted Sequencing, Whole Exome Sequencing, Whole Genome Sequencing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Targeted Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Whole Genome Sequencing
1.3 Market by Application
1.3.1 Global Next-Generation Sequencing (NGS) Services Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic & Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next-Generation Sequencing (NGS) Services Market Perspective (2021–2032)
2.2 Global Next-Generation Sequencing (NGS) Services Growth Trends by Region
2.2.1 Global Next-Generation Sequencing (NGS) Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Next-Generation Sequencing (NGS) Services Historic Market Size by Region (2021–2026)
2.2.3 Next-Generation Sequencing (NGS) Services Forecasted Market Size by Region (2027–2032)
2.3 Next-Generation Sequencing (NGS) Services Market Dynamics
2.3.1 Next-Generation Sequencing (NGS) Services Industry Trends
2.3.2 Next-Generation Sequencing (NGS) Services Market Drivers
2.3.3 Next-Generation Sequencing (NGS) Services Market Challenges
2.3.4 Next-Generation Sequencing (NGS) Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next-Generation Sequencing (NGS) Services Players by Revenue
3.1.1 Global Top Next-Generation Sequencing (NGS) Services Players by Revenue (2021–2026)
3.1.2 Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Players (2021–2026)
3.2 Global Top Next-Generation Sequencing (NGS) Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Next-Generation Sequencing (NGS) Services Revenue
3.4 Global Next-Generation Sequencing (NGS) Services Market Concentration Ratio
3.4.1 Global Next-Generation Sequencing (NGS) Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Sequencing (NGS) Services Revenue in 2025
3.5 Global Key Players of Next-Generation Sequencing (NGS) Services Head Offices and Areas Served
3.6 Global Key Players of Next-Generation Sequencing (NGS) Services, Products and Applications
3.7 Global Key Players of Next-Generation Sequencing (NGS) Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Next-Generation Sequencing (NGS) Services Breakdown Data by Type
4.1 Global Next-Generation Sequencing (NGS) Services Historic Market Size by Type (2021–2026)
4.2 Global Next-Generation Sequencing (NGS) Services Forecasted Market Size by Type (2027–2032)
5 Next-Generation Sequencing (NGS) Services Breakdown Data by Application
5.1 Global Next-Generation Sequencing (NGS) Services Historic Market Size by Application (2021–2026)
5.2 Global Next-Generation Sequencing (NGS) Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Next-Generation Sequencing (NGS) Services Market Size (2021–2032)
6.2 North America Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Next-Generation Sequencing (NGS) Services Market Size by Country (2021–2026)
6.4 North America Next-Generation Sequencing (NGS) Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next-Generation Sequencing (NGS) Services Market Size (2021–2032)
7.2 Europe Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Next-Generation Sequencing (NGS) Services Market Size by Country (2021–2026)
7.4 Europe Next-Generation Sequencing (NGS) Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size (2021–2032)
8.2 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size by Region (2021–2026)
8.4 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Next-Generation Sequencing (NGS) Services Market Size (2021–2032)
9.2 Latin America Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Next-Generation Sequencing (NGS) Services Market Size by Country (2021–2026)
9.4 Latin America Next-Generation Sequencing (NGS) Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size (2021–2032)
10.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size by Country (2021–2026)
10.4 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Introduction
11.1.4 Eurofins Scientific Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.1.5 Eurofins Scientific Recent Development
11.2 Natera
11.2.1 Natera Company Details
11.2.2 Natera Business Overview
11.2.3 Natera Next-Generation Sequencing (NGS) Services Introduction
11.2.4 Natera Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.2.5 Natera Recent Development
11.3 BGI
11.3.1 BGI Company Details
11.3.2 BGI Business Overview
11.3.3 BGI Next-Generation Sequencing (NGS) Services Introduction
11.3.4 BGI Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.3.5 BGI Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Next-Generation Sequencing (NGS) Services Introduction
11.4.4 Illumina Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.4.5 Illumina Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Next-Generation Sequencing (NGS) Services Introduction
11.5.4 Roche Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.5.5 Roche Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Details
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Next-Generation Sequencing (NGS) Services Introduction
11.6.4 LabCorp Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.6.5 LabCorp Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Introduction
11.7.4 Berry Genomics Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.7.5 Berry Genomics Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Introduction
11.8.4 Thermo Fisher Scientific Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Macrogen
11.9.1 Macrogen Company Details
11.9.2 Macrogen Business Overview
11.9.3 Macrogen Next-Generation Sequencing (NGS) Services Introduction
11.9.4 Macrogen Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.9.5 Macrogen Recent Development
11.10 Oxford Nanopore
11.10.1 Oxford Nanopore Company Details
11.10.2 Oxford Nanopore Business Overview
11.10.3 Oxford Nanopore Next-Generation Sequencing (NGS) Services Introduction
11.10.4 Oxford Nanopore Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.10.5 Oxford Nanopore Recent Development
11.11 Novogene
11.11.1 Novogene Company Details
11.11.2 Novogene Business Overview
11.11.3 Novogene Next-Generation Sequencing (NGS) Services Introduction
11.11.4 Novogene Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.11.5 Novogene Recent Development
11.12 Pacific Biosciences
11.12.1 Pacific Biosciences Company Details
11.12.2 Pacific Biosciences Business Overview
11.12.3 Pacific Biosciences Next-Generation Sequencing (NGS) Services Introduction
11.12.4 Pacific Biosciences Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.12.5 Pacific Biosciences Recent Development
11.13 Azenta Life Sciences
11.13.1 Azenta Life Sciences Company Details
11.13.2 Azenta Life Sciences Business Overview
11.13.3 Azenta Life Sciences Next-Generation Sequencing (NGS) Services Introduction
11.13.4 Azenta Life Sciences Revenue in Next-Generation Sequencing (NGS) Services Business (2021–2026)
11.13.5 Azenta Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Targeted Sequencing
 Table 3. Key Players of Whole Exome Sequencing
 Table 4. Key Players of Whole Genome Sequencing
 Table 5. Global Next-Generation Sequencing (NGS) Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Next-Generation Sequencing (NGS) Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Next-Generation Sequencing (NGS) Services Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Next-Generation Sequencing (NGS) Services Market Share by Region (2021–2026)
 Table 9. Global Next-Generation Sequencing (NGS) Services Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Next-Generation Sequencing (NGS) Services Market Share by Region (2027–2032)
 Table 11. Next-Generation Sequencing (NGS) Services Market Trends
 Table 12. Next-Generation Sequencing (NGS) Services Market Drivers
 Table 13. Next-Generation Sequencing (NGS) Services Market Challenges
 Table 14. Next-Generation Sequencing (NGS) Services Market Restraints
 Table 15. Global Next-Generation Sequencing (NGS) Services Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Next-Generation Sequencing (NGS) Services Market Share by Players (2021–2026)
 Table 17. Global Top Next-Generation Sequencing (NGS) Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Next-Generation Sequencing (NGS) Services Revenue, 2025
 Table 18. Ranking of Global Top Next-Generation Sequencing (NGS) Services Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Next-Generation Sequencing (NGS) Services Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Next-Generation Sequencing (NGS) Services, Headquarters and Area Served
 Table 21. Global Key Players of Next-Generation Sequencing (NGS) Services, Products and Applications
 Table 22. Global Key Players of Next-Generation Sequencing (NGS) Services, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Next-Generation Sequencing (NGS) Services Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Type (2021–2026)
 Table 26. Global Next-Generation Sequencing (NGS) Services Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Type (2027–2032)
 Table 28. Global Next-Generation Sequencing (NGS) Services Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Application (2021–2026)
 Table 30. Global Next-Generation Sequencing (NGS) Services Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Application (2027–2032)
 Table 32. North America Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Next-Generation Sequencing (NGS) Services Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Next-Generation Sequencing (NGS) Services Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Next-Generation Sequencing (NGS) Services Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Next-Generation Sequencing (NGS) Services Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Next-Generation Sequencing (NGS) Services Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Next-Generation Sequencing (NGS) Services Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size by Country (US$ Million), 2027–2032
 Table 47. Eurofins Scientific Company Details
 Table 48. Eurofins Scientific Business Overview
 Table 49. Eurofins Scientific Next-Generation Sequencing (NGS) Services Product
 Table 50. Eurofins Scientific Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 51. Eurofins Scientific Recent Development
 Table 52. Natera Company Details
 Table 53. Natera Business Overview
 Table 54. Natera Next-Generation Sequencing (NGS) Services Product
 Table 55. Natera Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 56. Natera Recent Development
 Table 57. BGI Company Details
 Table 58. BGI Business Overview
 Table 59. BGI Next-Generation Sequencing (NGS) Services Product
 Table 60. BGI Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 61. BGI Recent Development
 Table 62. Illumina Company Details
 Table 63. Illumina Business Overview
 Table 64. Illumina Next-Generation Sequencing (NGS) Services Product
 Table 65. Illumina Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 66. Illumina Recent Development
 Table 67. Roche Company Details
 Table 68. Roche Business Overview
 Table 69. Roche Next-Generation Sequencing (NGS) Services Product
 Table 70. Roche Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 71. Roche Recent Development
 Table 72. LabCorp Company Details
 Table 73. LabCorp Business Overview
 Table 74. LabCorp Next-Generation Sequencing (NGS) Services Product
 Table 75. LabCorp Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 76. LabCorp Recent Development
 Table 77. Berry Genomics Company Details
 Table 78. Berry Genomics Business Overview
 Table 79. Berry Genomics Next-Generation Sequencing (NGS) Services Product
 Table 80. Berry Genomics Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 81. Berry Genomics Recent Development
 Table 82. Thermo Fisher Scientific Company Details
 Table 83. Thermo Fisher Scientific Business Overview
 Table 84. Thermo Fisher Scientific Next-Generation Sequencing (NGS) Services Product
 Table 85. Thermo Fisher Scientific Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 86. Thermo Fisher Scientific Recent Development
 Table 87. Macrogen Company Details
 Table 88. Macrogen Business Overview
 Table 89. Macrogen Next-Generation Sequencing (NGS) Services Product
 Table 90. Macrogen Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 91. Macrogen Recent Development
 Table 92. Oxford Nanopore Company Details
 Table 93. Oxford Nanopore Business Overview
 Table 94. Oxford Nanopore Next-Generation Sequencing (NGS) Services Product
 Table 95. Oxford Nanopore Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 96. Oxford Nanopore Recent Development
 Table 97. Novogene Company Details
 Table 98. Novogene Business Overview
 Table 99. Novogene Next-Generation Sequencing (NGS) Services Product
 Table 100. Novogene Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 101. Novogene Recent Development
 Table 102. Pacific Biosciences Company Details
 Table 103. Pacific Biosciences Business Overview
 Table 104. Pacific Biosciences Next-Generation Sequencing (NGS) Services Product
 Table 105. Pacific Biosciences Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 106. Pacific Biosciences Recent Development
 Table 107. Azenta Life Sciences Company Details
 Table 108. Azenta Life Sciences Business Overview
 Table 109. Azenta Life Sciences Next-Generation Sequencing (NGS) Services Product
 Table 110. Azenta Life Sciences Revenue in Next-Generation Sequencing (NGS) Services Business (US$ Million), 2021–2026
 Table 111. Azenta Life Sciences Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Next-Generation Sequencing (NGS) Services Picture
 Figure 2. Global Next-Generation Sequencing (NGS) Services Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Next-Generation Sequencing (NGS) Services Market Share by Type: 2025 vs 2032
 Figure 4. Targeted Sequencing Features
 Figure 5. Whole Exome Sequencing Features
 Figure 6. Whole Genome Sequencing Features
 Figure 7. Global Next-Generation Sequencing (NGS) Services Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Next-Generation Sequencing (NGS) Services Market Share by Application: 2025 vs 2032
 Figure 9. Hospitals and Clinics Case Studies
 Figure 10. Biopharma Companies Case Studies
 Figure 11. Academic & Research Organizations Case Studies
 Figure 12. Others Case Studies
 Figure 13. Next-Generation Sequencing (NGS) Services Report Years Considered
 Figure 14. Global Next-Generation Sequencing (NGS) Services Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Next-Generation Sequencing (NGS) Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Next-Generation Sequencing (NGS) Services Market Share by Region: 2025 vs 2032
 Figure 17. Global Next-Generation Sequencing (NGS) Services Market Share by Players in 2025
 Figure 18. Global Next-Generation Sequencing (NGS) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Next-Generation Sequencing (NGS) Services Revenue in 2025
 Figure 20. North America Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Next-Generation Sequencing (NGS) Services Market Share by Country (2021–2032)
 Figure 22. United States Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Next-Generation Sequencing (NGS) Services Market Share by Country (2021–2032)
 Figure 26. Germany Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Next-Generation Sequencing (NGS) Services Market Share by Region (2021–2032)
 Figure 34. China Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Next-Generation Sequencing (NGS) Services Market Share by Country (2021–2032)
 Figure 42. Mexico Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Next-Generation Sequencing (NGS) Services Market Share by Country (2021–2032)
 Figure 46. Israel Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Next-Generation Sequencing (NGS) Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Eurofins Scientific Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 50. Natera Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 51. BGI Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 52. Illumina Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 53. Roche Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 54. LabCorp Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 55. Berry Genomics Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 57. Macrogen Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 58. Oxford Nanopore Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 59. Novogene Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 60. Pacific Biosciences Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 61. Azenta Life Sciences Revenue Growth Rate in Next-Generation Sequencing (NGS) Services Business (2021–2026)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS